Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Galit Bergerzon"'
Autor:
Haim Ben-Zvi, Shay Ben-Shachar, Dana Sagas, Doron Amichay, Anat Ben-Dor, Faten Gadban, Galit Bergerzon, Ran D. Balicer, Sheri Harari, Eti Eliassian, Amit Huppert, Shay Perchik, Eldad Kepten, Michael Leschinsky, Uriah Finkel, Yonat Shemer Avni, Maayan Tahor, Hala Gadban, Shifra Ken Dror, Orit Shimron, Rachel Levy, Adi Stern, Noam Harel, Merav Strauss, Loulou Saleh, Doron Nezer, Talia Kustin, Itamar Caspi
SummaryThe SARS-CoV-2 pandemic has been raging for over a year, creating global detrimental impact. The BNT162b2 mRNA vaccine has demonstrated high protection levels, yet apprehension exists that several variants of concerns (VOCs) can surmount the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4093329293e7c6bbec76df6ecc97741f
https://doi.org/10.1101/2021.04.06.21254882
https://doi.org/10.1101/2021.04.06.21254882
Autor:
Hala Gadban, Orit Shimron, Shay Perchik, Galit Bergerzon, Shifra Ken Dror, Haim Ben-Zvi, Maayan Tahor, Uriah Finkel, Michael Leshchinsky, Anat Ben-Dor, Talia Kustin, Shay Ben-Shachar, Faten Gadban, Noam Harel, Itamar Caspi, Ran D. Balicer, Merav Strauss, Rachel Levy, Loulou Saleh, Adi Stern, Dana Sagas, Doron Amichay, Elena Keren Taraday, Eldad Kepten, Yonat Shemer Avni, Doron Netzer, Amit Huppert, Sheri Harari, Eti Eliassian
Publikováno v:
Nature Medicine
The BNT162b2 mRNA vaccine is highly effective against SARS-CoV-2. However, apprehension exists that variants of concern (VOCs) may evade vaccine protection, due to evidence of reduced neutralization of the VOCs B.1.1.7 and B.1.351 by vaccine sera in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c892b5f365cf5a471ad52384b207187
